{"entity":{"type":"insider","cik":"0001307632","url":"/insider/0001307632","json_url":"/insider/0001307632.json","name":"Hawkins Richard J","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":23,"n_filings":16,"first":"2014-12-11","last":"2025-06-23","span_basis":"filed_date"},"name_variants":[{"name":"Hawkins Richard J","source":"filing","n_filings":16,"first_seen":"2014-12-11","last_seen":"2025-06-23"}],"transactions":[{"id":4027815,"accession":"0000950170-25-088895","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-088895","line_url":"/filing/0000950170-25-088895#line-1","is_derivative":false,"issuer_cik":"0001160308","issuer_name":"Savara Inc","issuer_ticker":"SVRA","issuer_name_source":null,"issuer_url":"/issuer/0001160308","owner_cik":"0001307632","owner_name":"Hawkins Richard J","owner_display_name":"Hawkins Richard J","owner_url":"/insider/0001307632","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":48225.0,"shares_display":"48,225","price_per_share":2.044,"price_display":"2.04","price_state":"stated","total_value":98571.9,"total_display":"98,571.90","total_whole":"98,572","shares_owned_after":115466.0,"shares_owned_after_display":"115,466","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-20","filed_date":"2025-06-23","scope":"insider"},{"id":2595868,"accession":"0000950170-24-136780","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-136780","line_url":"/filing/0000950170-24-136780#line-2","is_derivative":false,"issuer_cik":"0001160308","issuer_name":"Savara Inc","issuer_ticker":"SVRA","issuer_name_source":null,"issuer_url":"/issuer/0001160308","owner_cik":"0001307632","owner_name":"Hawkins Richard J","owner_display_name":"Hawkins Richard J","owner_url":"/insider/0001307632","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":3.3211,"price_display":"3.32","price_state":"stated","total_value":26568.8,"total_display":"26,568.80","total_whole":"26,569","shares_owned_after":67241.0,"shares_owned_after_display":"67,241","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-16","filed_date":"2024-12-16","scope":"insider"},{"id":2738034,"accession":"0000950170-24-107008","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-107008","line_url":"/filing/0000950170-24-107008#line-1","is_derivative":false,"issuer_cik":"0001095981","issuer_name":"PLUS THERAPEUTICS, INC.","issuer_ticker":"PSTV","issuer_name_source":null,"issuer_url":"/issuer/0001095981","owner_cik":"0001307632","owner_name":"Hawkins Richard J","owner_display_name":"Hawkins Richard J","owner_url":"/insider/0001307632","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4000.0,"shares_display":"4,000","price_per_share":1.499,"price_display":"1.50","price_state":"stated","total_value":5996.0,"total_display":"5,996.00","total_whole":"5,996","shares_owned_after":15188.0,"shares_owned_after_display":"15,188","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-13","filed_date":"2024-09-17","scope":"insider"},{"id":2117603,"accession":"0000950170-24-106605","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-106605","line_url":"/filing/0000950170-24-106605#line-1","is_derivative":false,"issuer_cik":"0001095981","issuer_name":"PLUS THERAPEUTICS, INC.","issuer_ticker":"PSTV","issuer_name_source":null,"issuer_url":"/issuer/0001095981","owner_cik":"0001307632","owner_name":"Hawkins Richard J","owner_display_name":"Hawkins Richard J","owner_url":"/insider/0001307632","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6285.0,"shares_display":"6,285","price_per_share":1.3543,"price_display":"1.35","price_state":"stated","total_value":8511.7755,"total_display":"8,511.78","total_whole":"8,512","shares_owned_after":11188.0,"shares_owned_after_display":"11,188","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-12","filed_date":"2024-09-16","scope":"insider"},{"id":2343052,"accession":"0000950170-24-057453","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-057453","line_url":"/filing/0000950170-24-057453#line-1","is_derivative":false,"issuer_cik":"0001095981","issuer_name":"PLUS THERAPEUTICS, INC.","issuer_ticker":"PSTV","issuer_name_source":null,"issuer_url":"/issuer/0001095981","owner_cik":"0001307632","owner_name":"Hawkins Richard J","owner_display_name":"Hawkins Richard J","owner_url":"/insider/0001307632","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4902.0,"shares_display":"4,902","price_per_share":2.04,"price_display":"2.04","price_state":"stated","total_value":10000.08,"total_display":"10,000.08","total_whole":"10,000","shares_owned_after":4903.0,"shares_owned_after_display":"4,903","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-08","filed_date":"2024-05-10","scope":"insider"},{"id":7994747,"accession":"0001209191-23-016526","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-016526","line_url":"/filing/0001209191-23-016526#line-1","is_derivative":false,"issuer_cik":"0001095981","issuer_name":"PLUS THERAPEUTICS, INC.","issuer_ticker":"PSTV","issuer_name_source":null,"issuer_url":"/issuer/0001095981","owner_cik":"0001307632","owner_name":"Hawkins Richard J","owner_display_name":"Hawkins Richard J","owner_url":"/insider/0001307632","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Series F Preferred Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1.0,"shares_display":"1","price_per_share":1000.0,"price_display":"1,000.00","price_state":"stated","total_value":1000.0,"total_display":"1,000.00","total_whole":"1,000","shares_owned_after":1.0,"shares_owned_after_display":"1","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-03","filed_date":"2023-03-06","scope":"insider"},{"id":6576033,"accession":"0001126234-22-000105","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001126234-22-000105","line_url":"/filing/0001126234-22-000105#line-2","is_derivative":false,"issuer_cik":"0001126234","issuer_name":"LUMOS PHARMA, INC.","issuer_ticker":"LUMO","issuer_name_source":null,"issuer_url":"/issuer/0001126234","owner_cik":"0001307632","owner_name":"Hawkins Richard J","owner_display_name":"Hawkins Richard J","owner_url":"/insider/0001307632","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":208.0,"shares_display":"208","price_per_share":8.8,"price_display":"8.80","price_state":"stated","total_value":1830.4,"total_display":"1,830.40","total_whole":"1,830","shares_owned_after":4469.0,"shares_owned_after_display":"4,469","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-09-23","filed_date":"2022-09-23","scope":"insider"},{"id":6576030,"accession":"0001126234-22-000105","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001126234-22-000105","line_url":"/filing/0001126234-22-000105#line-1","is_derivative":false,"issuer_cik":"0001126234","issuer_name":"LUMOS PHARMA, INC.","issuer_ticker":"LUMO","issuer_name_source":null,"issuer_url":"/issuer/0001126234","owner_cik":"0001307632","owner_name":"Hawkins Richard J","owner_display_name":"Hawkins Richard J","owner_url":"/insider/0001307632","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2214.0,"shares_display":"2,214","price_per_share":8.84,"price_display":"8.84","price_state":"stated","total_value":19571.76,"total_display":"19,571.76","total_whole":"19,572","shares_owned_after":4261.0,"shares_owned_after_display":"4,261","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-09-21","filed_date":"2022-09-23","scope":"insider"},{"id":6127690,"accession":"0001126234-22-000103","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001126234-22-000103","line_url":"/filing/0001126234-22-000103#line-2","is_derivative":false,"issuer_cik":"0001126234","issuer_name":"LUMOS PHARMA, INC.","issuer_ticker":"LUMO","issuer_name_source":null,"issuer_url":"/issuer/0001126234","owner_cik":"0001307632","owner_name":"Hawkins Richard J","owner_display_name":"Hawkins Richard J","owner_url":"/insider/0001307632","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1506.0,"shares_display":"1,506","price_per_share":8.75,"price_display":"8.75","price_state":"stated","total_value":13177.5,"total_display":"13,177.50","total_whole":"13,178","shares_owned_after":2047.0,"shares_owned_after_display":"2,047","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-09-20","filed_date":"2022-09-21","scope":"insider"},{"id":6127689,"accession":"0001126234-22-000103","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001126234-22-000103","line_url":"/filing/0001126234-22-000103#line-1","is_derivative":false,"issuer_cik":"0001126234","issuer_name":"LUMOS PHARMA, INC.","issuer_ticker":"LUMO","issuer_name_source":null,"issuer_url":"/issuer/0001126234","owner_cik":"0001307632","owner_name":"Hawkins Richard J","owner_display_name":"Hawkins Richard J","owner_url":"/insider/0001307632","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":541.0,"shares_display":"541","price_per_share":8.65,"price_display":"8.65","price_state":"stated","total_value":4679.65,"total_display":"4,679.65","total_whole":"4,680","shares_owned_after":541.0,"shares_owned_after_display":"541","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-09-19","filed_date":"2022-09-21","scope":"insider"},{"id":8690873,"accession":"0000899243-19-013799","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000899243-19-013799","line_url":"/filing/0000899243-19-013799#line-6","is_derivative":false,"issuer_cik":"0001160308","issuer_name":"Savara Inc","issuer_ticker":"SVRA","issuer_name_source":null,"issuer_url":"/issuer/0001160308","owner_cik":"0001307632","owner_name":"Hawkins Richard J","owner_display_name":"Hawkins Richard J","owner_url":"/insider/0001307632","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10409.0,"shares_display":"10,409","price_per_share":11.1602,"price_display":"11.16","price_state":"stated","total_value":116166.5218,"total_display":"116,166.52","total_whole":"116,167","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-15","filed_date":"2019-05-16","scope":"insider"},{"id":8690868,"accession":"0000899243-19-013799","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000899243-19-013799","line_url":"/filing/0000899243-19-013799#line-5","is_derivative":false,"issuer_cik":"0001160308","issuer_name":"Savara Inc","issuer_ticker":"SVRA","issuer_name_source":null,"issuer_url":"/issuer/0001160308","owner_cik":"0001307632","owner_name":"Hawkins Richard J","owner_display_name":"Hawkins Richard J","owner_url":"/insider/0001307632","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14591.0,"shares_display":"14,591","price_per_share":11.0654,"price_display":"11.07","price_state":"stated","total_value":161455.2514,"total_display":"161,455.25","total_whole":"161,455","shares_owned_after":10409.0,"shares_owned_after_display":"10,409","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-14","filed_date":"2019-05-16","scope":"insider"},{"id":3095246,"accession":"0001307632-16-000022","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001307632-16-000022","line_url":"/filing/0001307632-16-000022","is_derivative":false,"issuer_cik":"0000880771","issuer_name":"SCICLONE PHARMACEUTICALS INC","issuer_ticker":"SCLN","issuer_name_source":null,"issuer_url":"/issuer/0000880771","owner_cik":"0001307632","owner_name":"Hawkins Richard J","owner_display_name":"Hawkins Richard J","owner_url":"/insider/0001307632","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":120000.0,"shares_display":"120,000","price_per_share":10.3727,"price_display":"10.37","price_state":"stated","total_value":1244724.0,"total_display":"1,244,724.00","total_whole":"1,244,724","shares_owned_after":24363.0,"shares_owned_after_display":"24,363","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-12","filed_date":"2016-08-16","scope":"insider","n_lines":4},{"id":8218751,"accession":"0001307632-15-000010","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001307632-15-000010","line_url":"/filing/0001307632-15-000010#line-2","is_derivative":false,"issuer_cik":"0000880771","issuer_name":"SCICLONE PHARMACEUTICALS INC","issuer_ticker":"SCLN","issuer_name_source":null,"issuer_url":"/issuer/0000880771","owner_cik":"0001307632","owner_name":"Hawkins Richard J","owner_display_name":"Hawkins Richard J","owner_url":"/insider/0001307632","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4570.0,"shares_display":"4,570","price_per_share":9.2715,"price_display":"9.27","price_state":"stated","total_value":42370.755,"total_display":"42,370.76","total_whole":"42,371","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-01","filed_date":"2015-06-02","scope":"insider"},{"id":8935679,"accession":"0001307632-15-000008","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001307632-15-000008","line_url":"/filing/0001307632-15-000008#line-2","is_derivative":false,"issuer_cik":"0000880771","issuer_name":"SCICLONE PHARMACEUTICALS INC","issuer_ticker":"SCLN","issuer_name_source":null,"issuer_url":"/issuer/0000880771","owner_cik":"0001307632","owner_name":"Hawkins Richard J","owner_display_name":"Hawkins Richard J","owner_url":"/insider/0001307632","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10430.0,"shares_display":"10,430","price_per_share":9.3175,"price_display":"9.32","price_state":"stated","total_value":97181.525,"total_display":"97,181.52","total_whole":"97,182","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-05-29","filed_date":"2015-06-01","scope":"insider"},{"id":8661633,"accession":"0001307632-15-000006","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001307632-15-000006","line_url":"/filing/0001307632-15-000006#line-1","is_derivative":false,"issuer_cik":"0000880771","issuer_name":"SCICLONE PHARMACEUTICALS INC","issuer_ticker":"SCLN","issuer_name_source":null,"issuer_url":"/issuer/0000880771","owner_cik":"0001307632","owner_name":"Hawkins Richard J","owner_display_name":"Hawkins Richard J","owner_url":"/insider/0001307632","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11982.0,"shares_display":"11,982","price_per_share":9.4429,"price_display":"9.44","price_state":"stated","total_value":113144.8278,"total_display":"113,144.83","total_whole":"113,145","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-05-26","filed_date":"2015-05-26","scope":"insider"},{"id":8850153,"accession":"0001307632-15-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001307632-15-000004","line_url":"/filing/0001307632-15-000004#line-1","is_derivative":false,"issuer_cik":"0000880771","issuer_name":"SCICLONE PHARMACEUTICALS INC","issuer_ticker":"SCLN","issuer_name_source":null,"issuer_url":"/issuer/0000880771","owner_cik":"0001307632","owner_name":"Hawkins Richard J","owner_display_name":"Hawkins Richard J","owner_url":"/insider/0001307632","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3700.0,"shares_display":"3,700","price_per_share":9.7064,"price_display":"9.71","price_state":"stated","total_value":35913.68,"total_display":"35,913.68","total_whole":"35,914","shares_owned_after":11982.0,"shares_owned_after_display":"11,982","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-05-21","filed_date":"2015-05-26","scope":"insider"},{"id":8776527,"accession":"0001307632-15-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001307632-15-000002","line_url":"/filing/0001307632-15-000002#line-1","is_derivative":false,"issuer_cik":"0000880771","issuer_name":"SCICLONE PHARMACEUTICALS INC","issuer_ticker":"SCLN","issuer_name_source":null,"issuer_url":"/issuer/0000880771","owner_cik":"0001307632","owner_name":"Hawkins Richard J","owner_display_name":"Hawkins Richard J","owner_url":"/insider/0001307632","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18727.0,"shares_display":"18,727","price_per_share":9.1617,"price_display":"9.16","price_state":"stated","total_value":171571.1559,"total_display":"171,571.16","total_whole":"171,571","shares_owned_after":15682.0,"shares_owned_after_display":"15,682","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-05-14","filed_date":"2015-05-18","scope":"insider"},{"id":6758857,"accession":"0001307632-14-000008","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001307632-14-000008","line_url":"/filing/0001307632-14-000008#line-2","is_derivative":false,"issuer_cik":"0000880771","issuer_name":"SCICLONE PHARMACEUTICALS INC","issuer_ticker":"SCLN","issuer_name_source":null,"issuer_url":"/issuer/0000880771","owner_cik":"0001307632","owner_name":"Hawkins Richard J","owner_display_name":"Hawkins Richard J","owner_url":"/insider/0001307632","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":740.0,"shares_display":"740","price_per_share":8.8197,"price_display":"8.82","price_state":"stated","total_value":6526.578,"total_display":"6,526.58","total_whole":"6,527","shares_owned_after":34409.0,"shares_owned_after_display":"34,409","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-11","filed_date":"2014-12-11","scope":"insider"},{"id":6758852,"accession":"0001307632-14-000008","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001307632-14-000008","line_url":"/filing/0001307632-14-000008#line-1","is_derivative":false,"issuer_cik":"0000880771","issuer_name":"SCICLONE PHARMACEUTICALS INC","issuer_ticker":"SCLN","issuer_name_source":null,"issuer_url":"/issuer/0000880771","owner_cik":"0001307632","owner_name":"Hawkins Richard J","owner_display_name":"Hawkins Richard J","owner_url":"/insider/0001307632","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14851.0,"shares_display":"14,851","price_per_share":8.7947,"price_display":"8.79","price_state":"stated","total_value":130610.0897,"total_display":"130,610.09","total_whole":"130,610","shares_owned_after":35149.0,"shares_owned_after_display":"35,149","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-10","filed_date":"2014-12-11","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":23,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":9,"open_market":true},{"code":"S","label":"Open-market sale","n":14,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":23},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001160308","name":"Savara Inc","url":"/issuer/0001160308","role":"Director","n_filings":3,"first_seen":"2019-05-16","last_seen":"2025-06-23"},{"type":"issuer","type_label":"ISSUER","cik":"0001095981","name":"PLUS THERAPEUTICS, INC.","url":"/issuer/0001095981","role":"Director","n_filings":4,"first_seen":"2023-03-06","last_seen":"2024-09-17"},{"type":"issuer","type_label":"ISSUER","cik":"0001126234","name":"LUMOS PHARMA, INC.","url":"/issuer/0001126234","role":"Director, Officer (Chief Executive Officer)","n_filings":2,"first_seen":"2022-09-21","last_seen":"2022-09-23"},{"type":"issuer","type_label":"ISSUER","cik":"0000880771","name":"SCICLONE PHARMACEUTICALS INC","url":"/issuer/0000880771","role":"Director","n_filings":7,"first_seen":"2014-12-11","last_seen":"2016-08-16"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001307632","retrieved_at":"2026-08-23T02:38:44+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}